On a molecular basis, mosaiques scans the body using proteomic analysis.


This is the existential benefit for our life in chronic diseases including cancer.

mosaiques / protexam proteome analysis:

  • can detect the diseases before organ damage, and
  • use this revolution for early detection and targeted therpy (personalised medicine).



mosaiques/power-of-proteomics = end of 'divining rod race':

  • proteome-biomarker of the diseases on the molecular basis,
  • use the highest quality clinical database.


mosaiques group comprises subsidiaries with different key aspects:

Share by: